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Abstract 
Three full-length cDNA clones encoding the guinea pig A 1 adenosine receptor have been isolated by polymerase chain 
reaction (PCR) and low-stringency hybridization screening of a guinea pig brain cDNA library. These three cDNAs, though 
differing in their 5' untranslated regions, contain the same open reading frame encoding a 326 amino acid residue protein with 
seven hydrophobic a-helices long enough to form the transmembrane domains, suggesting that it belongs to the G protein-cou- 
pled receptor superfamily. This protein is highly homologous to the A 1 adenosine receptors previously cloned from other species. 
Pharmacological characterization of this receptor transiently expressed in mammalian cells demonstrates that, despite its high 
homology to A 1 adenosine receptors of other species, the guinea pig A 1 adenosine receptor displays a unique pharmacological 
profile: high affinity for the Al-selective antagonist CPX, yet very low affinity for some Al-selective agonists such as CCPA, 
CHA and R-PIA. Northern blotting for different guinea pig tissues and in situ hybridization for guinea pig brain sections reveal 
an abundant and broad distribution of mRNA of this A 1 subtype receptor in the brain. 
Keywords: G protein-coupled receptor; Polymerase chain reaction; Radioligand binding; Mammalian cell expression; In situ 
hybridization 
1. Introduction 
Adenosine not only plays important roles in energy 
metabolism and in the cellular synthesis of nucleic 
acids, but also acts as a neurotransmitter to mediate a 
variety of central physiological functions, such as seda- 
tion, pain modulation, and pre-synaptic inhibition of 
neurotransmitter release. Peripherally, it has been im- 
plicated in the inhibition of cardiovascular activity, in 
the regulation of renal glomerular filtration, and in the 
modulation of the immune system and of white blood 
cell and platelet functions [24,36]. Adenosine binds to 
its specific membrane receptors and activates signal 
transduction pathways through second messengers. 
Based on their effects on adenylyl cyclase, adenosine 
receptors have been classified into two main types: the 
A t type which inhibits adenylyl cyclase and decreases 
intracellular cAMP levels, and the A 2 type which stim- 
ulates adenylyl cyclase and increases cAMP [32]. The 
cloning of A1, A 2 and other types of adenosine recep- 
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tors from several species [13-17,8,19,25,26,28,31,35,37] 
has facilitated the molecular study and understanding 
of this subfamily of G protein-coupled receptors. 
Species differences among the adenosine receptors 
in their interactions with agonists and antagonists have 
been reported based on receptor binding studies using 
mammalian brain membrane preparations [7,33]. 
Therefore, cloning and characterization of the adeno- 
sine receptors from commonly used laboratory-animal 
species would be of importance and interest for the 
study of structure-activity relationship of receptors. 
Here we report the cloning of an A 1 adenosine recep- 
tor from guinea pig brain, the pharmacological and 
functional characterization of this receptor in tran- 
siently transfected cells, and its mRNA expression in 
guinea pig brain and other tissues. 
2. Materials and methods 
2.1. mRNA preparation and cDNA library construction 
Total RNA was isolated from male Hartley guinea pig brains by 
guanidinium thiocyanate extraction followed by centrifugation in 
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cesium chloride solution [29]. Poly(A) ÷ RNA was purified using 
oligo-dT cellulose spun column (Pharmacia). The construction of a 
cDNA library was principally based on the method developed by 
Okayama and Berg [22] and modified by Gubler and Hoffman [10]. 
The first strand cDNA was synthesized by AMV reverse transcrip- 
tase using oligo(dT)-Notl Primer-Adaptor [oligo(dT)i5 containing 
Not l site on its 5' end, Promega], the second strand cDNA was 
synthesized using E. coli DNA polymerase I and RNase H. After 
treatment with T 4 DNA polymerase to blunt their ends, the double- 
stranded cDNAs were ligated with BstXI linker (Invitrogen) by T 4 
ligase at 14°C for 24 h. The cDNAs were digested by restriction 
enzyme Not I to create Not I sticky ends, then loaded on 1% agarose 
gel for size fractionation, The cDNAs with size > 1.5 kb were 
electroeluted from the gel onto DE81 ion-exchange paper (What- 
man) and recovered by eluting with 1 M NaCI. The cDNAs were 
unidirectionally inserted into the B s t X I - N o t I  sites of pME18S 
expression vector [18,34] by T4 ligase, and transformed into host 
DH5a competent cells by electroporation (Bio-Rad). The resulting 
cDNA library contains 1.8 × 106 independent clones with insert sizes 
from 1.5 to 5.0 kb. 
2.2. Oligonucleotide primer design and PCR amplification 
Six degenerate oligonucleotides were synthesized based on pub- 
lished G protein-coupled receptor cDNA sequences. 
Three forward: 











(6) 5'-C(G)A(T)IC( G)A(T)ICCIACA(G)AAA(G)TAIATA(G)AAI- 
GGA(G)TT-3'. 
Every possible combination of one forward and one reverse 
oligonucleotides was employed as one set of primers for polymerase 
chain reaction (PCR) [27]. 
Five fmol of guinea pig brain cDNAs were used as PCR tem- 
plates, 1 /~M of each primer, 200/zM of each dNTP and 5 units of 
Taq DNA Polymerase (Perkin-Elmer) were used in each 100 #1 
volume reaction. The PCR temperature cycle on the DNA Thermal 
Cycler (Coy Laboratory) was set as follows: for the first five cycles, 
denaturation at 94°C for 1 min, annealing at 37°C for 2 min, 
extension at 50°C for 5 min; for the next 30 cycles, denaturation at 
94°C for 1 min, annealing at 50°C for 2 min and extension at 72°C for 
3 rain; the last five cycles had an extension time of 10 rain at 72°C in 
each cycle. 
Aliquots of the PCR products were directly loaded onto 1.2% 
agarose gel to analyze their sizes. DNAs from bands of 0.4-1.2 kb 
were recovered by electroelution, ligated into the EcoRV site of 
pBluescript KS II (Stratagene) for sequencing and for preparation of 
32p-labeled probes for colony hybridization. 
2.3. Colony hybridization and DNA sequencing 
Approximately 3 x 10 s E. coli colonies from the guinea pig brain 
cDNA library were lifted onto Nytran filters (S&S). Each PCR 
product probe was labeled with 3Zp by random priming [6]. The 
conditions of low-stringency hybridization were: 35% formamide, 
5 × SSPE, 5 × Denhardt's solution, 0.5% SDS, 100/.Lg/ml denatured 
salmon sperm DNA (Pharmacia), 1 × 106 cpm probe/ml, 42°C, 24 h. 
Washing was conducted at 37°C three times with 2×SSPE, 0.2% 
SDS for 30 rain each. Positive colonies were picked and further 
purified to single clones by second round screening and southern 
hybridization with 32P-probes. 
Both strands of cloned cDNA were sequenced by dideoxynu- 
cleotide chain termination method [30] with Sequenase (USB). DNA 
and deduced protein sequences were analyzed by Genetics Com- 
puter Group programs (Version 7). 
2.4. Mammalian cell transfection and receptor binding assay 
COS-7 cells were transfected by electroporation [21] with plas- 
mids purified by CsCI gradient centrifugation. Exponentially growing 
COS-7 cells were plated (5 × 105 cells/10 cm dish) in DMEM, 10% 
FCS. After one day in culture at 37°C, 5% CO2, cells were harvested 
and washed twice with D-PBS, then resuspended in 1 ml D-PBS 
containing 10 /zg of the plasmid DNA encoding the guinea pig A 1 
receptor (gpAiR) inserted in the pME18S vector. The cell suspen- 
sions were kept in a sterile electroporation cuvette on ice for 5 min, 
and electroporated in a Cell-Porator (BRL) at 330/zF, 300 V, 4°C, 
then placed on ice again for 5 rain. They were subsequently sus- 
pended in 10 ml DMEM containing 10% FCS, and cultured at 37°C, 
5% CO2. 
After 3 days in culture, transfected cells were harvested by 
treatment with D-PBS (without calcium and magnesium) containing 
0.5 mM EDTA and 0.01% sodium azide, washed three times with 
KHB [115 mM NaCI, 4.8 mM KCI, 2.5 mM CaCI z, 5 mM MgC12, 25 
mM HEPES, pH adjusted to 7.4 with NaOH), and resuspended in 
KHB. Receptor binding assays were performed in 1 ml KHB with 
1 × 10 .5 cells. 
In order to distinguish different types of adenosine receptors, the 
tritiated A 1 agonists 2-chloro-N6-[cyclopentyl-2,3,4,5 - 3H]cyclopentyl- 
adenosine ([3H]CCPA, spec. act. 35.4 Ci/mmol), and cyclohydrox- 
yadenosine ([3H]CHA, 30.2 Ci/mmol), the A 1 antagonist 8-[dipro- 
pyl-2,8-3H(N)]cyclopentyl-l,3-dipropylxanthine ([3H]CPX, 108.0 
Ci/mmol), and the A 2 agonist [carboxyethyt-3H(N)]CGS 21680 (39.6 
Ci/mmol) (all from NEN) were used to label the binding sites. 
Unlabeled ligands used in binding assays included: the A j-selective 
agonists CCPA, CPA, and CHA; the relatively Al-selective agonists 
ADAC, R-PIA, and BA; the At-selective antagonists CPX and 
DPX; the relatively Al-selective antagonists XAC and IBMX; the 
Aa-selective agonist CGS 21680; relatively Az-selective agonist 
MECA; relatively Ae-selective antagonists DMPX, DPMX; and the 
non-selective agonist NECA, as well as adenosine and ATP. For the 
saturation studies, various concentrations of radiolabeled ligands 
were used, and nonspecific binding was determined in the presence 
of 10 izM unlabeled R-PIA for A 1 and l0/~M CGS 21680 for A 2. In 
one parallel experiment, 5 units/ml of adenosine deaminase were 
included in the binding assay buffer to determine the influence of 
endogenously released adenosine; in another parallel experiment, 
transfected cell membrane preparations in 50 mM Tris buffer (pH 
7.4) were used to assess the influence of salts in KHB on binding 
affinities. For  competition studies, minimum amounts of radiola- 
beled ligands were used to give about 2000 cpm specific binding per 
tube, and various concentration of unlabeled ligands were used to 
compete. The assay reactions were carried out at room temperature 
for 1.5 h and terminated by placement on ice for 5 rain. Bound and 
free radioligands were separated by filtration through glass fiber 
filters (#32, S&S) on a multi-channel cell harvester (M-24S, BrandeD. 
The filters were counted for radioactivity in scintillation solution. 
Binding assay data were analyzed by the Ligand program [20] and 
are presented as the mean value of three experiments. 
2.5. GTPase assay 
The experimental procedure for the GTPase assay was based on 
the method described by Cassel and Selinger [2]. Briefly, plasmid 
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pME18S-gpA1R transfected COS cell membranes were prepared by 
homogenization and centrifugation in 10 mM Tris-HCI buffer con- 
taining 0.1 mM EDTA, pH 7.5. Ten micrograms of membrane 
protein suspended in 10 ~1 were added to an 85 ~1 reaction mixture 
containing 0.5 mM [3~-32p]GTP, 1 mM AppNHp, 1 mM ATP, 1 mM 
Ouabain, 10 mM creatine phosphate, 5 units of creatine phosphoki- 
nase, 2 mM dithiothreitol, 5 mM MgCl 2, 100 mM NaC1, 0.1 mM 
EDTA, 12.5 mM Tris-HCl, pH 7.5. This mixture was kept on ice 
before the addition of adenosine receptor agonists. Immediately 
after the addition of the A t agonist CPA or R-PIA (10 /~M and 1 
/.~M) or the A 2 agonist CGS 21680 (10/~M), the reaction tubes were 
transferred to 37°C for 20 rain. The reaction was terminated by 
placing on ice, and adding 0.9 ml of stop solution containing 20 mM 
phosphoric acid and 5% activated charcoal, pH 2.3. After centrifuga- 
tion in an Eppendorf microcentrifuge at 4°C for 10 min, the radioac- 
tivities in the supernatants were measured. 
2.6. cAMP assay 
COS-7 cells transfected with plasmid pME18S-gpAIR were cul- 
tured in DMEM, 10%FCS for two days. After washing twice with 
IMDM, the cells were cultured in IMDM, 10% Hyclone FCS. 
Forskolin (1 p.M) was added to raise the intracellular cAMP levels, 
and then various adenosine ligands were added to the cell culture 
and incubated at 37°C for 30 rain. To terminate the reaction, 30% 
trichloroacetic acid (ice cold, equal volume to the cell culture media) 
was added to the dish. The cells were scraped into a glass test tube 
and put on ice for 30 min for a complete precipitation. After 
centrifugation at 2000 × g, 4°C for 10 min, the supernatant was ether 
extracted, lyophilized in a Speed Vac and resuspended in 50 mM 
Tris-HCl, 2 mM EDTA, pH 7.5. Cyclic AMP levels were measured 
with a cAMP Assay Kit (TRK 432, Amersham). 
2. Z Northern blot analysis 
mM Tris-HCl, pH 8.0) for 10 min at 37°C. Subsequently, sections 
underwent successive washes in water for 1 min, in 0.1 M tri- 
ethanolamine (pH 8.0, plus 0.25% acetic anhydride) for 10 min, and 
in 2 × SSC (0.3 mM NaCI, 0.03 mM sodium citrate, pH 7.2) for 5 min. 
Sections were then dehydrated through graded ethanol solutions and 
air dried. 
1.0x 106 dpm 35S-labeled riboprobes were diluted in hybridiza- 
tion buffer containing 75% formamide, 10% dextran sulfate, 3 X SSC, 
50 mM sodium phosphate buffer (pH 7.4), 1 x Denhardt's solution, 
0.1 mg/ml yeast tRNA and 10 mM dithiothreitol in a total volume of 
25 ml. The diluted probe was applied to post-fixed sections on a glass 
coverslip which was sealed into place with rubber cement, and 
hybridized overnight at 55°C in a humid environment. 
After hybridization, the rubber cement was removed and sections 
were washed in 2x  SSC for 5 min and then treated with RNase A 
(200 p~g/ml in 10 mM Tris-HC1, pH 8.0, containing 0.5 M NaCI) for 
60 min at 37°C. Subsequently, sections were washed in 2 × SSC for 5 
min, 1 x SSC for 5 min, 0.5 x SSC for 60 min at 55°C, 0.5 x SSC at 
room temperature for 5 rain, and then dehydrated in graded ethanol 
solutions and air dried. Sections were exposed to an X-ray film for 2 
days at room temperature. 
2. 9. In vitro receptor autoradiography 
[3H]CPX, [3H]CHA and [3H]CCPA binding studies on guinea 
pig brain horizontal sections (15 mm thick) were performed accord- 
ing to published methods [5]. Slide-mounted sections were incubated 
in 0.17 M Tris-HCl with 0.5 units/ml adenosine deaminase (pH 7.4) 
for 20 min, and then incubated with 2 nM [3H]CPX, or 10 nM 
[3H]CHA, or 10 nM [3H]CCPA for 90 min at room temperature. 
Slides were washed twice in incubation buffer for 5 min, and dried in 
a stream of cold air. Non-specific binding was determined in the 
presence of 2 /zM CPX. Sections were apposed to tritium-sensitive 
Hyperfilm (Amersham) at room temperature for 14 days. 
Total RNA was extracted from guinea pig whole brain and 
peripheral tissues with 5 M GITC solution (5 M guanididium isothio- 
cyanate, 10 mM EDTA, 50 mM Tris, and 8% fl-mercaptoethanol) 
and 5 M LiCI. The RNA samples (25 mg for each tissue) were 
electrophoresed on a 1% agarose gel in 1 × MOPS containing 6.6% 
formaldehyde, and then transferred onto a Nytran filter. The filter 
was hybridized with 7×105 cpm/ml [a-32p]UTP-labeled gpA1R 
cRNA probe under high-stringency conditions: 50% Formamide, 
5×SSPE, 5×Denhardt's reagent, 0.5% SDS, 70°C, for 24 h. The 
filter was washed once with 1 × SSPE, 0.5% SDS at 70°C for 30 min 
and three times with 0.1 X SSPE, 0.5% SDS at 70°C for 30 min and 
then exposed to an X-ray film (XAR-5, Kodak) with two intensifying 
screens for 6 days at -80°C. 
2.8. In situ hybridization 
All in situ hybridizations were conducted with [3SS]UTP-labeled 
cRNA riboprobes. A 1 cRNA riboprobe was produced from an 
XbaI-SacI fragment of the gpA1R cDNA ligated into pBluescript 
KS II using either the T 3 or T 7 RNA polymerases. This fragment 
(500 bp) encompasses the entire sequence of the third cytoplasmic 
loop, a region of least homology among G protein-coupled receptors. 
Labeled probe was separated from free nucleotides over a Sephadex 
G-50 column. Its specificity was confirmed by absence of signal both 
in sections hybridized with sense A 1 probe and in sections treated 
with RNase prior to hybridization with the antisense (cRNA) A 1 
probe. 
To examine major brain structures of the guinea pig, brain 
horizontal sections (15/~m thick) were prepared, and placed into 4% 
buffered paraformaldehyde at room temperature. After 1 h, slides 
were rinsed in PBS and treated with proteinase K (1 /~g/ml in 100 
3. Results 
3.1. Cloning o f  gpA  1R c D N A s  
S e q u e n c e  analysis  o f  s eve ra l  P C R - a m p l i f i e d  f rag-  
m e n t s  r e v e a l e d  d i f f e r e n t  s e q u e n c e s  w i t h  v a r i o u s  de -  
g r e e s  o f  h o m o l o g y  ( f r o m  6 2 %  to  8 8 % )  to  c D N A s  
e n c o d i n g  t h e  A 1 a n d  A 2 a d e n o s i n e  r e c e p t o r s  o f  t h e  
dog  a n d  rat .  T h e s e  P C R  p r o d u c t s  w e r e  l a b e l e d  wi th  
32p a n d  u s e d  as t h e  p r o b e s  to s c r e e n  the  g u i n e a  p ig  
b r a i n  p M E 1 8 S  c D N A  l ibrary  to  o b t a i n  f u l l - l e n g t h  
c lones .  S o m e  of  t h e  c l o n e s  w e  i so l a t ed  w e r e  f o u n d  to  
e n c o d e  t h e  g u i n e a  p ig  A z a d e n o s i n e  r e c e p t o r ,  wh ich  
we  h a v e  d e s c r i b e d  e l s e w h e r e  [19]. T w e n t y - o n e  pos i t ive  
c l o n e s  w e r e  f o u n d  to be  h igh ly  h o m o l o g o u s  to  A t 
a d e n o s i n e  r e c e p t o r .  A l t h o u g h  t h e y  all c o n t a i n e d  an 
i den t i ca l  l o n g  o p e n  r e a d i n g  f r a m e  a n d  an i d e n t i c a l  
3 ' - u n t r a n s l a t e d  r e g i o n  ( 3 ' U T ) ,  t h e  21 c l o n e s  e x h i b i t e d  
t h r e e  v a r i a n t  s e q u e n c e s  in t h e i r  5 ' U T  (Fig .  1). V a r i a n t  
I has  t h e  l onges t  5 ' U T  (508 bp) ;  t h e  5 ' U T  o f  v a r i a n t  II  
is s h o r t e r  a n d  exhib i t s  a b o u t  6 0 %  h o m o l o g y  to  tha t  o f  
v a r i a n t  I; t h e  5 ' U T  r e g i o n  o f  v a r i a n t  I I I  is i den t i ca l  to 
tha t  o f  v a r i a n t  I I  e x c e p t  fo r  a 34 bp  d e l e t i o n .  I t  is n o t  
k n o w n  w h e t h e r  this  5' U T  v a r i a t i o n  has  any  s ign i f i cance  
in t h e  r e g u l a t i o n  o f  t h e  exp res s ion ,  l oca l i z a t i on  a n d  
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(I) 1 GAGCGCTGCGCGGGAGCGAGGACGATGAGCTGCCGCGCGGTGCCCAGAGCCCAGCCCTGC 
61 CCGGCGCGGCCCCGGAACTCTGGGCGGCACCGCGTGCTGGGAAGTTTAGGCACTGCTCTG 
121 GGACCCCCTGCCGGCCAGCAGGCAGGATGGTGAGCTCACTGCATCCTGTTCTGTGGACAC 
(I) 181 AGGGTGGACAGAGCAGGGCGCGCGGGACCCTTGTGGGGTGTGTGTGTGCTGGGAGCTGCC 
(II) :::::::::::::::::::::::::::::::::::::::::: 
(III) ::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
(I) 241 TCACACCTGATACAAAGCCACTGGTGGAGTGAGTGCTGCTATTTTAAGTTGCTGAATGGA 
(II) a:c: ================================================= 
(III) :::: ::::::::::::::::::::::::::::::::::::::::::::::::: 
(I) 301 ACCTCTGGGGCTGCTCAAGGGAGGGGACAGAGGTTAGGCAGGGGAAGGGCTCAGGTGTCC 
(II) t:ac:a::::g ::c:::t:atg:ag:c::c:aggt:c:gg::cactg:cc::gg 
(III) ::::::::::: ::::::::::::::::::::::::::::::::::::::::::: 
(I) 361 TGGCCAATCTGGCAGGCACATCTCCCCAGGGTTGCCTGGACTCCTCTCCTCCTCCAGGCA 
(II) c:::tc:gg::::ca:g:gcgg:g::a::ttag:tg::ac::tg :::: 
(III) :::::::::::::::::::::::::::::::::::::::::::::::: common) 
(common sequence starts) 
(I) 421 GGCCTCCCCACCCCAGGCTTCCTGACCACA GGTGCCTACCTCGTGCCCCGTGGTGCTTGT 
(If) :::::::::::::::::::::::::::::::::: common) 
481 CTGCTGATGTGCCCAGCCTGTGCCCGCCATGCCGCACTCCGTCTCCGCCTTCCAGGCTGC 
M P H S V S A F Q A A Ii 
541 CTATATTGGCATCGAGGTGCTCATCGCCCTGGTCTCAGTACCTGGGAACGTGCTGGTGAT 
Y I G I E V L I A L V S V P G N V L V I 31 
TM-I 
601 TTGGGCTGTGAAGGTGAACCAGGCACTGCGGGATGCCACCTTCTGCTTCATCGCGTCACT 
W A V K V N Q A L R D A T F C F I A S L 51 
661 GGCAGTGGCTGATGTGGCAGTGGGTGCCTTGGTCATTCCACTGGCCATCCTCATCAACAT 
A V A D V A V G A L V I P L A I L I N I 71 
TM-2 ................. 
721 TGGGCCACAGACCTACTTCCACACCTGCCTTATGGTGGCCTGCCCTGTCTTGATCCTCAC 
G P Q T Y F H T C L M V A C P V L I L T 91 
TM-3--- 
781 CCAGAGCTCCATCCTGGCCCTGCTGGCCATTGCTGTGGACCGCTACCTCCGTGTCAAGAT 
Q S S I L A L L A I A V D R Y L R V K I Iii 
841 CCCTCTCCGGTACAAGACGGTGGTGACCCCACGGAGGGCAGCAGTGGCCATTGCTGGCTG 
P L R Y K T V V T P R R A A V A I A G C 131 
901 CTGGATTCTCTCCCTTGTGGTGGGCCTGACGCCTATGTTTGGTTGGAACAATCTGAGTAA 
W I L S L V V G L T P M F G W N N L S K 151 
.... TM-4 * 
961 GATAGAGATGGCATGGGCGGCCAATGGAAGCGTCGGGGAACCCGTGATCAAGTGCGAGTT 
I E M A W A A N G S V G E P V I K C E F 171 
1021 TGAGAAGGTCATCAGCATGGAGTACATGGTCTACTTCAACTTCTTTGTCTGGGTGCTGCC 
E K V I $ M E Y M V Y F N F F V W V L P 191 
-TM-5 
1081 GCCGCTGCTCCTCATGGTCCTCATCTACCTGGAGGTCTTCTACTTGATCCGAAAGCAGCT 
P L L L M V L I Y L E V F Y L L R K Q L 211 
1141 CAGCAAAAAAGTGTCGGCCTCCTCTGGTGACCCGCAGAAGTACTACGGGAAGGAGTTGAA 
S K K V S A S S G D P Q K Y Y G K E L K 231 
1201 GATTGCTAAGTCGCTGGCCCTCATCCTCTTCCTTTTTGCCCTTAGCTGGCTGCCCCTGCA 
I A K S L A L I L F L F A L S W L P L H 251 
1261 
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........... TM-6 
CATCCTGAACTGTATCACCCTCTTCTGTCCCACCTGCCACAAGCCCACCATCCTCACTTA 
I L N C I T L F C P T C H K P T I L T Y 
1321 CATTGCCATCTTCCTCACGCATGGCAATTCAGCCATGAACCCCATCGTCTATGCTTTCCG 
I A I F L T H G N S A M N P I V Y A F R 
................ TM-7 
1381 CATCCAGAAGTTCCGGGTGACCTTTCTAAAGATTTGGAATGACCACTTCCGCTGCCAGCC 




















































Fig. 1. Nucleotide and deduced amino acid sequence of gpA1R. I, II, and III are the three variants. Nucleotides of Variant I are numbered on 
the left of the rows and amino acids on the right. Colons (:) indicate identities with sequences immediately above. Possible N-glycosylation sites 
(*) are marked, and polyadenylation signal sequence underlined. Putative hydrophobic transmembrane domains TM-1 through TM-7 are 
identified according to hydrophobisity analysis [12] and are underlined with broken lines. The sequence has been deposited in the GenBank 
database (accession no. U04279). 
stability of the mRNAs,  or is due to recombination, or 
is even an artifact of the cDNA library construction, 
though the high sequence-similarity of the three vari- 
ants makes the last possibility very unlikely. Since 
variation in the untranslated regions does not alter the 
protein-coding sequence, it is unlikely to affect the 
propert ies of the encoded receptor  protein itself, in- 
cluding the ligand binding profile. Therefore,  we cho- 
sen variant I (named gpA~R) for all subsequent stud- 
ies. 
3.2. Sequence analysis o f  gpAiR  
Clone gpA1R contains an insert of 2,837 bp includ- 
ing a poly(A) tail. A long open reading frame is found 
after an A T G  (methionine) at position 509-511. The 
sequences around this A T G  fit the Kozak consensus 
sequence for an eukaryotic translation initiation site 
[11]. Several in-frame stop codons are located up- 
stream of this ATG.  This open reading frame encodes 
a protein composed of 326 amino acids (including the 
first methionine) (Fig. 1), with a calculated molecular 
mass of 36,551 Da. The other two variants encode the 
same protein. 
The deduced amino acid sequence of gpA~R shows 
high homology to the previously cloned A 1 adenosine 
receptors from other species: 91% identity to dog A 1, 
93% to rat A1, 91% to bovine A1, and 95% to human 
A 1 (Fig. 2). It also shares a substantial degree of 
homology with other types of adenosine receptors: 
49% identity to dog A2a , 50% to human A2a , 50% to 
rat A2a , 49% to guinea pig A2a , 47% to rat and human 
A2b, and 45% to rat A 3. Its similarities with other 
members  of the G protein-coupled receptor superfam- 
ily are lower but significant (for example, within the 
t ransmembrane domains, 28% identity with human 
fl2-adrenergic receptor,  27% with human H 2 histamine 
receptor,  25% with human D 1 dopamine receptor,  27% 
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with rat 5-HT1c receptor,  23% with rat substance P 
receptor,  23% with rat cannab in iod  receptor,  and  18% 
with mouse thyrotropin-releasing hormone  receptor).  
Hydrophobici ty analysis (method of Kytc & Doolit- 
tie) [12] of g p A I R  revealed the existence of seven 
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Fig. 2. Amino acid sequence comparison of cloned A1 adenosine receptors. The deduced amino acid sequence of guinea pig A1 (GPAI) is in 
single-letter form and numbered on the top. Dashed lines in the A1 sequences of human [15], rat [26], dog [13], cow [35] and rabbit (la) represent 
amino-acid residues identical to those in GPAI. Dots represent the gaps of alignment. 
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amino-acid residues, sufficiently long to form an a-helix 
which could span the cell membrane. These hydropho- 
bic regions possess the highest similarities among G 
protein-coupled receptors. The gpA1R does not con- 
tain a hydrophobic signal sequence at its N-terminus. 
Several features of the primary structure of gpA]R 
are noteworthy and are also conserved in all other 
cloned A 1 receptors: Being 326 amino acids in length, 
it is one of the smallest members of the G protein-cou- 
pled receptor superfamily cloned to date; its N-termi- 
nal extracellular region before the TM I is very short 
(< 10 residues), and does not contain any potential 
N-glycosylation sites; on the other hand, there are two 
potential N-glycosylation sites in the second extracellu- 
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Fig. 3. Radio-ligand receptor binding assays on gpAiR transfected COS-7 cells. A,B: saturation curves of [3H]CPX, [3H]CCPA and [3H]CHA 
specific binding. Ten /~M of unlabeled R-PIA are used to produce total displacement and define the background. Note wide range of 
concentrations tested and different x-axis scale in B. C: competition of [3H]CPX specific binding by CPX ( • ) ,  XAC (zx), CPA (*), CCPA ( • ) ,  
R-PIA ( , ) ,  IBMX (e), CHA ([2), NECA (D), DPX (1~), DPMX (×), ADAC (m), adenosine (I-~]), BA (-), DMPX (m), ATP (1~), MECA (+), 
CGS21680 (~). 
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Fig. 3 (continued). 
lar loop; though it couples to Gi protein to inhibit 
adenylyl cyclase (data shown below), gpA~R has a very 
short third intracellular loop (only 34 amino acids), 
which is distinct from more prototypical Gi-coupled 
receptors (e.g. D 2 dopamine receptor) which contain a 
long third intracellular loop of about 130-140 residues; 
the short C-terminal intracellular tail (36 amino acids) 
contains only a single threonine residue and no serine 
residue, possibly indicating a minor role of phosphory- 
lation in modifying this domain. However, in the third 
intracellular loop, there are five serines and three 
tyrosines, which may participate in mechanisms of re- 
ceptor regulation via phosphorylation. 
3.3. Receptor binding assay of transfected COS-7 cells 
Untransfected COS-7 cells, do not express either A~ 
or A z adenosine receptor mRNA, nor do they demon- 
strate detectable [3H] CPX and [3H]CGS 21680 bind- 
ing. Thus, COS-7 cells were transfected with plasmid 
gpA~R, and binding assays (both saturation and com- 
petition studies) were performed on whole cells. Cells 
transfected with plasmid gpA~R expressed high-affin- 
ity, saturable specific binding for the selective A~ an- 
tagonist [3H]CPX (K d = 0.13 nM), with specific bind- 
ing representing about 75-80% of total binding (Fig. 
3A). However, the selective A 1 agonists [3H]CCPA and 
[3H]CHA showed only low affinity binding to gpAlR: 
[3H]CCPA Kd: > 50 nM; [3H]CHA Kd: > 100 nM 
(Fig. 3B). Several experiments were conducted in an 
attempt to improve these binding affinities: binding 
assays were performed with transfected COS-7 cell 
membrane preparations in Tris buffer in contrast to 
whole cells in KHB; studies were carried out in the 
presence of adenosine deaminase; different concentra- 
tions of Mg 2+ were employed; finally, co-transfection 
of gpA~R with either rat G i la ,  2a or 3a subunits was 
attempted. All these studies yielded similar results, 
with low affinity for those A~ agonists (data not shown). 
The selective A 2 agonist [3H]CGS 21680 did not bind 
to gpAIR (not shown). However, in parallel experi- 
ment using a cloned guinea pig A 2 receptor cDNA 
(gpAzR) and the same expression system, both A a- 
selective agonist CGS21680 and A 2 antagonist DMPX 
bound well, and all the relatively A a-selective and 
non-selective adenosine agonists displayed appreciable 
binding affinities toward this guinea pig A z receptor, 
which in good agreement with the literature-reported 
values [19]; in another control experiment using guinea 
pig brain membrane preparations, [3H]CCPA and 
[3H]CHA did show high-affinity binding (K d 0.67 nM 
and 13.84 nM, respectively), ruling out the possibility 
of technical problems in our transfection system and 
binding assays. 
In competition studies, the selective A1 antagonist 
CPX competed very well for [3H]CPX binding in 
gpA~R transfected COS-7 cells, and the non-selective 
adenosine antagonist XAC and the selective A] ago- 
nist CPA were moderate competitors; however, the 
selective A~ agonists CCPA, CHA and R-PIA com- 
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peted very poorly. Other  ligands such as the A~ ago- 
nists BA and ADAC,  and non-selective agonists NECA, 
and the A~ antagonist DPX and IBMX were all poor 
competitors. The A 2 agonist CGS 21680 and antago- 
nist DMPX,  as well as ATP and ADP did not compete 
[3H]CPX binding at all. The rank order of potency of 
these ligands in displacing [3H]CPX binding to 
gpA~R-transfected cells is as follows: CPX ( K  i 0.17 
riM) >> XAC (3.54 n M ) >  CPA (13.1 nM) >> CCPA 
(81.0 n M ) >  R-PIA (98.3 n M ) -  IBMX (102 n M ) >  
C H A  (138 nM) >> N E C A  = DPX (492 n M ) >  DPMX 
(736 n M ) >  A D A C  ( >  1400 n M ) >  adenosine ( >  1800 
n M ) >  BA, ATP, ADP,  D M P X  ( >  2000 n M ) >  CGS 
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3.4. The effects of  A 1 ligands on GTPase activity and 
cAMP levels in gpA1R-transfected COS cells 
0.4 
The A 1 agonists CPA and R-PIA stimulated GT- 
Pase activity up to more than 32% from control level, 
and reduced forskolin-induced cAMP level by about 
40% in g p A I R  transfected cells. These effects could be 
blocked by the A 1 antagonist CPX (Table 1). The A 2 
agonist CGS 21680 had little effect on GTPase  activity 
and cAMP levels in the same transfectants. The A t- 
selective agonist CPA did not significantly affect the 
GTPase  activity and did not decrease the cAMP levels 
in COS-7 cells transfected with plasmid pME18S- 
gpAER [19]. " 
3.5. Northern blot analysis 
Northern blot analysis of  total R N A  from guinea pig 
brain, heart, lung, spleen, kidney, liver, stomach, and 
intestine with gpA~R cRNA probe showed a hy- 
bridized broad band centered at 3.0 kb in the brain. 
After  longer exposure, a faint broad band of same size 
was also found in heart, spleen and kidney (Fig. 4). 
3.6. In situ hybridization and receptor autoradiography 
As can be seen from Fig. 5, the highest levels of 
g p A t R  m R N A  expression were evident within the 
cerebellum, the hippocampal  formation and neocortex. 
In the hippocampus,  the distribution of g p A t R  m R N A  
Fig. 4. Northern hybridization of RNAs from different guinea pig 
tissues. Lanes are: (1) brain, (2) heart, (3) lung, (4) spleen, (5) kidney, 
(6) liver, (7) stomach, and (8) intestine. The molecular weight esti- 
mate was based on an RNA ladder (BRL) and a Ribosomal RNA 
marker (Pharmacia). 
was heterogeneous: high levels of expression were 
found in the pyramidal cell layer of CA subfields and 
lower levels in the dentate gyrus and subiculum. This 
subfield distribution is comparable to the hippocampal 
distribution of A t binding sites as labeled with [3H]CPX 
(Fig. 5). Within the cortex, gpA1R m R N A  expression 
was most prominent  in intermediate and deep cortical 
layers. Again, this is in agreement  with the cortical 
distribution of [3H]CPX binding. Lower levels of both 
gpA1R m R N A  and A 1 binding were found in the 
caudate nucleus, septal nuclei and thalamic regions. 
The distribution of gpA1R m R N A  and [3H]CPX bind- 
ing were generally in agreement,  except that the bind- 
ing of [3H]CPX in cerebellum was significantly low. 
Autoradiographic examination of both [3H]CHA and 
[3H]CCPA binding revealed an anatomical distribution 
Table 1 
GTPase and cAMP assays on gpAiR-transfected COS-7 cells 
Control R-PIA (p~M) CPA (/.t M) R-PIA (10/zM) CGS21680 
10 1 0.1 10 1 0.1 + CPX (10/zM) (10/zM) 
GTPase activity (%) 100 + 4 132 + 4* 118 5:5 104 ± 3 135 + 7* 120 + 6 101 5:4 102 ± 3 98 5:5 
Cyclic AMP level (%) 100 5:3 61 + 5* 83 5:6 94 ± 4 59 + 8* 85 ± 5 97 5:7 99 + 6 102 + 4 
Data are presented as mean + S.E. of triplicates. GTPase activities without the application of ligands and forskolin-raised cAMP levels in 
transfected COS-7 cells were measured as control. *P < 0.05, as compared with control (Student t-test). In the same experiments in COS-7 cells 
transfected with plasmid pME18S-gpA2R , upon the application of 10 /zM CPA, GTPase activity was only slightly increased to 107 _+ 4, and 
forskolin-raised cAMP level was unchanged as compared with the control [19]. 
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almost identical to that obtained using [3H]CPX, ex- 
cept that in cerebellum the signals of the former two 
were stronger than the latter (data not shown). 
4. Discussion 
In this report, we describe a guinea pig cDNA 
encoding a novel protein with the following features: 
(a) The deduced protein gpA1R sequence shows a 
topology of seven hydrophobic a-helices, characteristic 
of the G protein-coupled receptor superfamily; it is 
most homologous to adenosine receptors cloned from 
other species, with a higher degree of sequence iden- 
tity to A~ (91-95%) than to A 2 (47-51%). 
(b) The gpA1R, when expressed in COS cells, binds 
the Al-selective antagonist CPX with high affinity, and 
also generally prefers most Al-selective ligands over 
A2-selective ligands, although it exhibits low affinity 
toward several classical A l-agonists. 
(c) Agonist activation of expressed gpA1R in COS cells 
increases GTPase activity and decreases intracellular 
cAMP levels. 
(d)The gpA1R mRNA exhibits a distinctive distribu- 
tion in brain, which parallels the pattern of A 1 recep- 
tor autoradiography. 
These results are generally consistent with the char- 
acteristics of an A 1 type adenosine receptor. There- 
fore, we conclude that the cloned gpAlR encodes a 
guinea pig A~ adenosine receptor. 
However, despite its high sequence-similarity (91- 
95%) to A1 adenosine receptors from other species 
(dog, rat, bovine, and human), the cloned gpAiR dis- 
played a unique pharmacological profile: the most in- 
teresting feature is its low-affinity binding to a group of 
Al-selective agonists such as CCPA and CHA which 
Fig. 5. Specific expression of gpAiR mRNA in brain. Comparative in situ hybridization with gpA1R cRNA probe (A) and autoradiographic 
localization of A 1 receptor sites (B) (antagonist [3H]CPX, 2 nM) in horizontal sections of guinea pig brain. CI'x, neocortex; CPu, caudate/puta- 
men; CA3/4. field C A  3 and C A  4 (Ammon's horn); CBL, cerebellum. 
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are reported to have high-affinity binding for A 1 recep- 
tors cloned from other species [14,15,17,26,35]. 
We first examined the possibility of whether the 
low-affinity binding was a result of technical problems. 
The quality of the tritiated ligands [3H]CCPA and 
[3H]CHA was confirmed in receptor-autoradiographic 
experiments using rat and guinea pig brains, where 
studies at low nanomolar concentrations of ligands 
indicated similar levels of agonist binding in the two 
species; in a side-by-side binding experiment using 
both guinea pig brain membrane and transfected COS 
cell membrane preparations, we actually obtained high 
affinities (K d 0.67 nM for [3H]CCPA, 13.84 nM for 
[3H]CHA) with the brain membranes, which agreed 
with reported values in the literature, while still low 
affinities with transfected cell membranes. In addition, 
NEN confirmed the chemical purity (> 99%) of the 
ligands upon our request. We also demonstrated that 
the g i values for unlabeled CCPA, CHA and other 
agonists obtained in competition studies agreed well 
with K d values from the saturation binding studies 
utilizing the tritiated agonists. Therefore, we conclude 
that the low-affinity binding of CCPA, CHA and sev- 
eral other agonists is due to an intrinsic property of the 
cloned receptor (at least in our transient expression 
system) rather than the quality of the ligands we used. 
This being the case, there are several possibilities to 
consider: (i) The gpA~R may not have been properly 
coupled to the appropriate G protein in the transiently 
transfected host COS cells; (ii) gpAlR may actually be 
the guinea pig counterpart of the same A 1 subtype 
cloned from other species, but the divergent residues 
confer to it a unique binding profile distinctive from 
others, which was previously unrecognized; (iii) gpAlR 
may be a new subtype (low-affinity) of A 1 adenosine 
receptors, raising the possibility that there may exist 
another A1 subtype in guinea pig with a profile identi- 
cal to that of the high-affinity A~ receptors cloned 
from other species. We shall discuss each of these 
possibilities in turn. 
Is it possible that the expressed receptor may not 
couple to the right G protein, since the host cells are 
from different species? At least, it is not true for other 
cloned A~ adenosine receptors. The m I receptors 
cloned from dog, rat, bovine and human [14,15,26,35], 
have been reported by other laboratories to have high 
affinity for Al-agonists CCPA and CHA when ex- 
pressed in monkey COS cells. In contrast, gpAiR 
exhibited low-affinity binding for CCPA and CHA in 
COS cells, the affinities being about 1-2 orders of 
magnitude lower than those for other species. We have 
shown that A 1 agonists CPA and R-PIA increased 
GTPase activity and decreased forskolin-induced cAMP 
levels in gpA1R-transfected COS-7 cells, suggesting 
that gpA~R expressed in COS cells did, in fact, func- 
tionally couple to G protein(s). It should also be noted 
that in side-by-side experiments the same COS cells 
transfected with a guinea pig A 2 receptor cDNA, 
under the same conditions, have displayed very high 
affinity for A2-selective agonists and appreciable affini- 
ties for A 1- and non-selective agonists [19]. Thus, it is 
unlikely that the observed low-affinity binding is due to 
the improper coupling of guinea pig A 1 receptor with 
monkey G protein in COS cells as compared to the 
natural coupling in guinea pig brain. A side-by-side 
binding comparison of this gpA1R with an cloned A t 
receptor from other species, using the same expression 
vector and the same host cells under same conditions, 
is needed to further address this issue. 
It is possible that gpA~R represents the guinea pig 
counterpart of the main known A t adenosine receptor 
subtype described for other species, but with quite 
different properties. There has been evidence that 
same receptor subtypes from different species, can 
exhibit distinct pharmacological properties. In the case 
of serotonin receptors, human 5-HT~B and rat 5-HT m 
are 93% identical, but their pharmacological profiles 
differ in terms of their binding for several key ligands. 
When residue Thr 355 in the human 5-HTIB receptor 
was changed by site-directed mutagenesis to Asn which 
was the corresponding residue in the rat 5-HTtB, the 
mutated human 5-HT m displayed a pharmacological 
profile identical to that of the rat 5-HT m [23]. A 
similar situation may apply to the cloned guinea pig A t 
receptor. Although gpAtR has > 90% amino acid 
sequence identity to other A t receptors from different 
species, it is possible that specific changes in key amino 
acids may cause substantial differences in interaction 
with the agonists tested. 
However, it is also possible that another A t adeno- 
sine receptor subtypes exist in the guinea pig brain 
which would have the same property of those from 
other species, and that the cDNA we have identified 
codes for a novel receptor subtype with low affinity for 
agonists but high affinity for antagonists. Results from 
side-by-side experiments indicate that endogenous A1 
receptors with high affinity for CCPA and CHA do 
exist in guinea pig brain, as evidenced in the sub- and 
low-nanomolar binding of the same agonists in brain 
membrane preparations and in receptor autoradioa- 
graphic studies. This possibility needs to be confirmed 
by molecular cloning. 
If gpA1R is a unique subtype, one would expect that 
it may exhibit a distinct distribution. However, this 
does not appear to be the case. In the autoradio- 
graphic study, we have observed that the high-affinity 
[3H]CCPA and [3H]CHA binding distribution were 
very similar to the high-affinity [3H]CPX binding (ex- 
cept in the cerebellum). The binding of both agonists 
and antagonist, in turn, paralleled the in situ hybridiza- 
tion distribution revealed by using the gpA~R probe. 
We do not know whether the high-affinity binding sites 
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are encoded by the same gpAtR gene, or by a different 
gene with parallel expression. The possibility that two 
different receptor subtypes with a shared endogenous 
ligand may be co-localized is not without precedent. In 
the case of the melanocortin receptor family, several 
receptors have been cloned and their distributions in 
brain appeared identical as revealed by in situ hy- 
bridization [9]. 
Of the possibilities we have considered above, we 
tend to favor the idea that we have cloned a low-affin- 
ity A ~ receptor subtype, which may either exist uniquely 
in guinea pig, or may have counterparts in other species. 
However, we cannot eliminate other possibilities, such 
as the existence in the guinea pig brain of unique 
factors or modification mechanisms which may endow 
this receptor with a high affinity for agonists. 
By Northern blot analysis, we have determined that 
gpA1R mRNA is expressed in the brain, heart, kidney, 
and spleen. Compared to the expression level of the 
guinea pig A 2 adenosine receptor [19], the present 
results indicate that A t adenosine receptor mRNA is 
more abundant in guinea pig brain than is A 2 receptor 
mRNA [19]. In the periphery, adenosine, via stimula- 
tion of A 1 adenosine receptors, can regulate myocar- 
dial, renal, and immune functions [36]. In particular, 
the stimulation of A1 adenosine receptors decreases 
heart rate and myocardial contractility [4]. In the kid- 
ney, adenosine can decrease cortical tubular produc- 
tion of cAMP and hormone-induced production of 
cAMP [1]. Evidence also indicates that adenosine is 
involved in the immune system, where activation of A~ 
adenosine receptors promotes neutrophil chemotaxis 
in response to tissue injury and bacterial infection [3]. 
Presumably, adenosine receptors are present in spleen 
because older neutrophils and other lymphocytes are 
harvested by the spleen. Given these reported func- 
tions of adenosine, the peripheral distribution of 
gpAtR mRNA is consistent with the idea that A 1 
adenosine receptors may mediate some of the effects 
in the cardiovascular, renal, and immune systems, as 
well as the CNS. 
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